PATIENT PHENOTYPES AND SGLT-2 INHIBITION IN TYPE 2 DIABETES MELLITUS: INSIGHTS FROM THE EMPA-REG OUTCOME TRIAL
Sharma A, Ofstad A, Ahmad T, Zinman B, Zwiener I, Fitchett D, Wanner C, George J, Hantel S, Desai N, Mentz R. PATIENT PHENOTYPES AND SGLT-2 INHIBITION IN TYPE 2 DIABETES MELLITUS: INSIGHTS FROM THE EMPA-REG OUTCOME TRIAL. Canadian Journal Of Cardiology 2020, 36: s71. DOI: 10.1016/j.cjca.2020.07.143.Peer-Reviewed Original Research